225 related articles for article (PubMed ID: 19524896)
1. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
2. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
3. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
4. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
5. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
6. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
7. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
Levy G; Malik M; Britten J; Gilden M; Segars J; Catherino WH
Fertil Steril; 2014 Jul; 102(1):272-281.e2. PubMed ID: 24825427
[TBL] [Abstract][Full Text] [Related]
8. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
Norian JM; Malik M; Parker CY; Joseph D; Leppert PC; Segars JH; Catherino WH
Reprod Sci; 2009 Dec; 16(12):1153-64. PubMed ID: 19700613
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle.
Tian R; Wang Z; Shi Z; Li D; Wang Y; Zhu Y; Lin W; Gui Y; Zheng XL
Fertil Steril; 2013 Jan; 99(1):256-263.e3. PubMed ID: 23043685
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
12. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays.
Malik M; Catherino WH
Fertil Steril; 2007 May; 87(5):1166-72. PubMed ID: 17222838
[TBL] [Abstract][Full Text] [Related]
13. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
14. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
17. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells.
Islam MS; Castellucci C; Fiorini R; Greco S; Gagliardi R; Zannotti A; Giannubilo SR; Ciavattini A; Frega NG; Pacetti D; Ciarmela P
J Cell Physiol; 2018 Sep; 233(9):7143-7156. PubMed ID: 29574773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]